Journal
TOXINS
Volume 14, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/toxins14030168
Keywords
snakebite; antivenom therapy; second-generation antivenom; 'big four' snakes
Categories
Funding
- Wellcome Trust DBT India Alliance Fellowship [IA/I/19/2/504647]
- DST-FIST [SR/FST/LS-II/2018/233]
Ask authors/readers for more resources
Snake envenomation causes high mortality and morbidity rates in the Indian subcontinent. Commercial Indian antivenoms, however, have poor performance in neutralizing venom and require large volumes for treatment, resulting in harmful side effects. This study demonstrates the effectiveness of chromatographic purification in enhancing the dose efficacy of antivenom therapy, improving venom recognition and neutralization potential, and countering the morbid effects of highly venomous snakes in India.
Snake envenoming afflicts the Indian subcontinent with the highest rates of mortality (47,000) and morbidity globally. The only effective treatment for snakebites is the administration of antivenom, which is produced by the hyperimmunisation of equines. Commercial Indian antivenoms, however, have been shown to exhibit a poor preclinical performance in neutralising venom, as a result of inter- and intrapopulation snake venom variation. Additionally, their poor dose effectiveness necessitates the administration of larger volumes of antivenom for treatment, leading to several harmful side effects in snakebite victims, including serum sickness and fatal anaphylaxis. In this study, we employed chromatographic purification to enhance the dose efficacy of commercial Indian antivenoms. The efficacy of this 'second-generation' antivenom was comparatively evaluated against six other marketed antivenoms using a number of in vitro and in vivo preclinical assays, which revealed its superior venom recognition capability. Enhanced purity also resulted in significant improvements in dose effectiveness, as the 'second-generation' antivenom exhibited a 3 to 4.5 times increased venom neutralisation potential. Furthermore, preclinical assays revealed the increased effectiveness of the 'second-generation' antivenom in countering morbid effects inflicted by the 'big four' Indian snakes. Thus, we demonstrate the role of simpler purification steps in significantly enhancing the effectiveness of snakebite therapy in regions that are most affected by snakebites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available